The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Self-assembling protein nanoparticles in the design of vaccines
Open accessAbstract
For over 100 years, vaccines have been one of the most effective medical interventions for reducing infectious disease, and are estimated to save millions of lives globally each year. Nevertheless, many diseases are not yet preventable by vaccination. This large unmet medical need demands further research and the development of novel vaccines with high efficacy and safety. Compared to the 19th and early 20th century vaccines that were made of killed, inactivated, or live-attenuated pathogens, modern vaccines containing isolated, highly purified antigenic protein subunits are safer but tend to induce lower levels of protective immunity. One strategy to overcome the latter is to design antigen nanoparticles: assemblies of polypeptides that present multiple copies of subunit antigens in well-ordered arrays with defined orientations that can potentially mimic the repetitiveness, geometry, size, and shape of the natural host-pathogen surface interactions. Such nanoparticles offer a collective strength of multiple binding sites (avidity) and can provide improved antigen stability and immunogenicity. Several exciting advances have emerged lately, including preclinical evidence that this strategy may be applicable for the development of innovative new vaccines, for example, protecting against influenza, human immunodeficiency virus, and respiratory syncytial virus. Here, we provide a concise review of a critical selection of data that demonstrate the potential of this field. In addition, we highlight how the use of self-assembling protein nanoparticles can be effectively combined with the emerging discipline of structural vaccinology for maximum impact in the rational design of vaccine antigens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Nair, H., Nokes, D. J., Gessner, B. D., Dherani, M., Madhi, S. A., Singleton, R. J., O'Brien, K. L., Roca, A., Wright, P. F., Bruce, N., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60206-1 · Cited by 2,773
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Bachmann, M. F., & Jennings, G. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2868 · Cited by 2,106
Leaver-Fay (2011) · doi:10.1016/b978-0-12-381270-4.00019-6 · Cited by 1,904
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
Garland, S. M., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Harper, D. M., Leodolter, S., Tang, G. W. K., Ferris, D. G., Steben, M., Bryan, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061760 · Cited by 1,886
There's plenty of room at the bottom
Feynman, R. P. (1999) · California Institute of Technology eBooks · doi:10.1201/b10107-3 · Cited by 1,444
Predicting protein structures with a multiplayer online game
Cooper, S., Khatib, F., Treuille, A., Barbero, J., Lee, J., Beenen, M., Leaver-Fay, A., Baker, D., Popović, Z., & players, F. (2010) · Nature · doi:10.1038/nature09304 · Cited by 1,368
Paavonen, J., Jenkins, D., Bosch, F. X., Naud, P., Salmerón, J., Wheeler, C. M., Chow, S.-N., Apter, D. L., Kitchener, H. C., Castellsague, X., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60946-5 · Cited by 1,315
Kirnbauer, R., Booy, F., Cheng, N., Lowy, D. R., & Schiller, J. T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12180 · Cited by 1,110
Structural Symmetry and Protein Function
Goodsell, D. S., & Olson, A. J. (2000) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.29.1.105 · Cited by 950 · cited 1×
“While many natural proteins have acquired self-assembling properties during evolution [13], the de novo engineering of protein assemblies is challenging.”
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
Kanekiyo, M., Wei, C.-J., Yassine, H. M., McTamney, P. M., Boyington, J. C., Whittle, J. R. R., Rao, S. S., Kong, W.-P., Wang, L., & Nabel, G. J. (2013) · Nature · doi:10.1038/nature12202 · Cited by 885
Synthesis and assembly of hepatitis B virus surface antigen particles in yeast
Valenzuela, P., Medina, A., Rutter, W. J., Ammerer, G., & Hall, B. D. (1982) · Nature · doi:10.1038/298347a0 · Cited by 877
Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein
Jiang, X., Wang, M., Graham, D. Y., & Estes, M. K. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6527-6532.1992 · Cited by 860
Native protein sequences are close to optimal for their structures
Kuhlman, B., & Baker, D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.19.10383 · Cited by 810
Zhu, F.-C., Zhang, J., Zhang, X.-F., Zhou, C., Wang, Z.-Z., Huang, S.-J., Wang, H., Yang, C.-L., Jiang, H.-M., Cai, J.-P., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61030-6 · Cited by 803
Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy
Böttcher, B., Wynne, S. A., & Crowther, R. A. (1997) · Nature · doi:10.1038/386088a0 · Cited by 791
Solving the structure of human H ferritin by genetically engineering intermolecular crystal contacts
Lawson, D. M., Artymiuk, P. J., Yewdall, S. J., Smith, J. M. A., Livingstone, J. C., Treffry, A., Luzzago, A., Levi, S., Arosio, P., Cesareni, G., et al. (1991) · Nature · doi:10.1038/349541a0 · Cited by 777 · cited 1×
“Several high-resolution structures of ferritin have been determined, confirming thatHelicobacter pylori ferritin is made of 24 identical protomers [90], whereas in animals, there are ferritin light and heavy chains that can assemble alone or combine with different ratios into particles of 24 subunits [91,92].”
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
Jardine, J., Julien, J.-P., Menis, S., Ota, T., Kalyuzhniy, O., McGuire, A., Sok, D., Huang, P.-S., MacPherson, S., Jones, M., et al. (2013) · Science · doi:10.1126/science.1234150 · Cited by 770 · cited 3×
“Jardine et al. engineered LS to display an optimized sub-component (termed, eOD-GT6) of the wild-type gp120 antigen from the Env trimer [99].”
Synthetic Nanoparticles for Vaccines and Immunotherapy
Irvine, D. J., Hanson, M. C., Rakhra, K., & Tokatlian, T. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00109 · Cited by 763
There’s plenty of room at the bottom
Feynman, R. P. (2011) · Resonance · doi:10.1007/s12045-011-0109-x · Cited by 762
A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants
The RTS, S. C. T. P. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1208394 · Cited by 752
Human hepatitis B vaccine from recombinant yeast
McAleer, W. J., Buynak, E. B., Maigetter, R. Z., Wampler, D. E., Miller, W. J., & Hilleman, M. R. (1984) · Nature · doi:10.1038/307178a0 · Cited by 739
Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
Yassine, H. M., Boyington, J. C., McTamney, P. M., Wei, C.-J., Kanekiyo, M., Kong, W.-P., Gallagher, J. R., Wang, L., Zhang, Y., Joyce, M. G., et al. (2015) · Nature Medicine · doi:10.1038/nm.3927 · Cited by 699
Computational Design of Self-Assembling Protein Nanomaterials with Atomic Level Accuracy
King, N. P., Sheffler, W., Sawaya, M. R., Vollmar, B. S., Sumida, J. P., André, I., Gonen, T., Yeates, T. O., & Baker, D. (2012) · Science · doi:10.1126/science.1219364 · Cited by 650
Plotkin, S. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400472111 · Cited by 642
Bache, E. B., Agnandji, S. T., Lell, B., Fernandes, J. F., Abossolo, B. P., Kabwende, A. L., Adégnika, A. A., Mordmüller, B. G., Kremsner, P. G., Loembé, M. M., et al. (2015) · The Lancet · doi:10.15496/publikation-6508 · Cited by 642
Drexler, K. E. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.9.5275 · Cited by 598
Virus-like particles: Passport to immune recognition
Grgacic, E. V. L., & Anderson, D. A. (2006) · Methods · doi:10.1016/j.ymeth.2006.07.018 · Cited by 582
Proof of principle for epitope-focused vaccine design
Correia, B. E., Bates, J. T., Loomis, R. J., Baneyx, G., Carrico, C., Jardine, J. G., Rupert, P., Correnti, C., Kalyuzhniy, O., Vittal, V., et al. (2014) · Nature · doi:10.1038/nature12966 · Cited by 555
Accurate design of co-assembling multi-component protein nanomaterials
King, N. P., Bale, J. B., Sheffler, W., McNamara, D. E., Gonen, S., Gonen, T., Yeates, T. O., & Baker, D. (2014) · Nature · doi:10.1038/nature13404 · Cited by 551
Oyewumi, M. O., Kumar, A., & Cui, Z. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.89 · Cited by 547
Crowther, R. (1994) · Cell · doi:10.1016/0092-8674(94)90142-2 · Cited by 512
Cloned Viral Protein Vaccine for Foot-and-Mouth Disease: Responses in Cattle and Swine
Kleid, D. G., Yansura, D., Small, B., Dowbenko, D., Moore, D. M., Grubman, M. J., McKercher, P. D., Morgan, D. O., Robertson, B. H., & Bachrach, H. L. (1981) · Science · doi:10.1126/science.6272395 · Cited by 498
Norovirus Vaccine against Experimental Human Norwalk Virus Illness
Atmar, R. L., Bernstein, D. I., Harro, C. D., Al-Ibrahim, M. S., Chen, W. H., Ferreira, J., Estes, M. K., Graham, D. Y., Opekun, A. R., Richardson, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1101245 · Cited by 490
Self-assembling peptides and proteins for nanotechnological applications
Rajagopal, K., & Schneider, J. P. (2004) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2004.06.006 · Cited by 476
Nanohedra: Using symmetry to design self assembling protein cages, layers, crystals, and filaments
Padilla, J. E., Colovos, C., & Yeates, T. O. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041614998 · Cited by 441
Prophylactic human papillomavirus vaccines
Lowy, D. R. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28607 · Cited by 428
The effect of air pollution on human physiological function in China: a longitudinal study
Guo, Y., Li, S., Zhou, Y., Chen, L., Chen, S., Yao, T., Qin, T., & Wu, S. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00612-1 · Cited by 423
The global value of vaccination
Ehreth, J. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00623-0 · Cited by 408
Rose, R. C., Bonnez, W., Reichman, R. C., & Garcea, R. L. (1993) · Journal of Virology · doi:10.1128/jvi.67.4.1936-1944.1993 · Cited by 381
Long-Term Efficacy of a Hepatitis E Vaccine
Zhang, J., Zhang, X.-F., Huang, S.-J., Wu, T., Hu, Y.-M., Wang, Z.-Z., Wang, H., Jiang, H.-M., Wang, Y.-J., Yan, Q., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1406011 · Cited by 378
Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site
Kanekiyo, M., Bu, W., Joyce, M. G., Meng, G., Whittle, J. R. R., Baxa, U., Yamamoto, T., Narpala, S., Todd, J.-P., Rao, S. S., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.043 · Cited by 366
Vaccines, new opportunities for a new society
Rappuoli, R., Pizza, M., Del Giudice, G., & De Gregorio, E. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402981111 · Cited by 335
Self-citationImproved immunogenicity of a peptide epitope after fusion to hepatitis B core protein
Clarke, B. E., Newton, S. E., Carroll, A. R., Francis, M. J., Appleyard, G., Syred, A. D., Highfield, P. E., Rowlands, D. J., & Brown, F. (1987) · Nature · doi:10.1038/330381a0 · Cited by 333
Self-assembly of purified polyomavirus capsid protein VP1
Salunke, D. M., Caspar, D. L. D., & Garcea, R. L. (1986) · Cell · doi:10.1016/0092-8674(86)90071-1 · Cited by 318
Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine
YUSIBOV, V (2002) · Vaccine · doi:10.1016/s0264-410x(02)00260-8 · Cited by 311
Structure of a designed protein cage that self-assembles into a highly porous cube
Lai, Y.-T., Reading, E., Hura, G. L., Tsai, K.-L., Laganowsky, A., Asturias, F. J., Tainer, J. A., Robinson, C. V., & Yeates, T. O. (2014) · Nature Chemistry · doi:10.1038/nchem.2107 · Cited by 297
Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
Coleman, C. M., Liu, Y. V., Mu, H., Taylor, J. K., Massare, M., Flyer, D. C., Glenn, G. M., Smith, G. E., & Frieman, M. B. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.04.016 · Cited by 293
Structure of a 16-nm Cage Designed by Using Protein Oligomers
Lai, Y.-T., Cascio, D., & Yeates, T. O. (2012) · Science · doi:10.1126/science.1219351 · Cited by 278
Keating, G. M., & Noble, S. (2003) · Drugs · doi:10.2165/00003495-200363100-00006 · Cited by 261
Nanoparticles and microparticles as vaccine-delivery systems
Singh, M., Chakrapani, A., & O’Hagan, D. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.5.797 · Cited by 259
Kajigaya, S., Fujii, H., Field, A., Anderson, S., Rosenfeld, S., Anderson, L. J., Shimada, T., & Young, N. S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4646 · Cited by 249
From the circumsporozoite protein to the RTS,S/AS candidate vaccine
Cohen, J., Nussenzweig, V., Vekemans, J., & Leach, A. (2010) · Human Vaccines · doi:10.4161/hv.6.1.9677 · Cited by 247
Vaccines in historic evolution and perspective: a narrative of vaccine discoveries
Hilleman, M. R. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00434-x · Cited by 227
Generation of protein lattices by fusing proteins with matching rotational symmetry
Sinclair, J. C., Davies, K. M., Vénien-Bryan, C., & Noble, M. E. M. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.122 · Cited by 227
JEGERLEHNER, A. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00266-9 · Cited by 226
Modeling Symmetric Macromolecular Structures in Rosetta3
DiMaio, F., Leaver-Fay, A., Bradley, P., Baker, D., & André, I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020450 · Cited by 214
Goldinger, S. M., Dummer, R., Baumgaertner, P., Mihic‐Probst, D., Schwarz, K., Hammann‐Haenni, A., Willers, J., Geldhof, C., Prior, J. O., Kündig, T. M., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201142361 · Cited by 201
Structure-based design of peptides that self-assemble into regular polyhedral nanoparticles
Raman, S., Machaidze, G., Lustig, A., Aebi, U., & Burkhard, P. (2006) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2006.04.007 · Cited by 185
Inflexal®V a trivalent virosome subunit influenza vaccine: production
Mischler, R., & Metcalfe, I. C. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00512-1 · Cited by 183
Crystal Structures of Four Types of Human Papillomavirus L1 Capsid Proteins
Bishop, B., Dasgupta, J., Klein, M., Garcea, R. L., Christensen, N. D., Zhao, R., & Chen, X. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706380200 · Cited by 183
Pimentel, T. A. P. F., Yan, Z., Jeffers, S. A., Holmes, K. V., Hodges, R. S., & Burkhard, P. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2008.00746.x · Cited by 182
Virus-Like Particle Vaccine Conferred Complete Protection Against a Lethal Influenza Virus Challenge
Galarza, J. M., Latham, T., & Cupo, A. (2005) · Viral Immunology · doi:10.1089/vim.2005.18.365 · Cited by 176
Designing supramolecular protein assemblies
Yeates, T. O., & Padilla, J. E. (2002) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(02)00350-0 · Cited by 175
Kaba, S. A., Brando, C., Guo, Q., Mittelholzer, C., Raman, S., Tropel, D., Aebi, U., Burkhard, P., & Lanar, D. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901957 · Cited by 175
Adaptations of nanoscale viruses and other protein cages for medical applications
LEE, L., & WANG, Q. (2006) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2006.07.009 · Cited by 168
A Recombinant Viruslike Particle Influenza A (H7N9) Vaccine
Fries, L. F., Smith, G. E., & Glenn, G. M. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1313186 · Cited by 167
Electron microscopy of hepatitis B core antigen synthesized in E. coli
Cohen, B. J., & Richmond, J. E. (1982) · Nature · doi:10.1038/296677a0 · Cited by 162
Glenn, G. M., Fries, L. F., Thomas, D. N., Smith, G., Kpamegan, E. P., Lu, H., Flyer, D. C., Jani, D., Hickman, S. P., & Piedra, P. A. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv406 · Cited by 161
Human papillomavirus infection and the primary and secondary prevention of cervical cancer
Lowy, D. R., Solomon, D., Hildesheim, A., Schiller, J. T., & Schiffman, M. (2008) · Cancer · doi:10.1002/cncr.23704 · Cited by 160
Safety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adults
Cox, M. M. J., Izikson, R., Post, P. L., & Dunkle, L. M. (2015) · Therapeutic Advances in Vaccines · doi:10.1177/2051013615595595 · Cited by 155
Smith, G., Raghunandan, R., Wu, Y., Liu, Y., Massare, M. J., Nathan, M., Zhou, B., Lu, H., Boddapati, S., Li, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050852 · Cited by 153
de la Cruz, V. F., Lal, A. A., & McCutchan, T. F. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68927-6 · Cited by 144
Structural vaccinology starts to deliver
Dormitzer, P. R., Grandi, G., & Rappuoli, R. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2893 · Cited by 143
Self-citationBrown, C. S., van Lent, J. W. M., Vlak, J. M., & Spaan, W. J. M. (1991) · Journal of Virology · doi:10.1128/jvi.65.5.2702-2706.1991 · Cited by 142
Bernardis, F. D., Amacker, M., Arancia, S., Sandini, S., Gremion, C., Zurbriggen, R., Moser, C., & Cassone, A. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.069 · Cited by 141
Galarza, J. M., Latham, T. E., & Cupo, A. (2005) · Viral Immunology · doi:10.1089/vim.2005.18.244 · Cited by 129
(2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0452-5 · Cited by 119
Wiedermann, U., Wiltschke, C., Jasińska, J., Kundi, M., Zurbriggen, R., Garner‐Spitzer, E., Bartsch, R., Steger, G. G., Pehamberger, H., Scheiner, O., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0666-9 · Cited by 116
A Poliovirus Neutralization Epitope Expressed on Hybrid Hepatitis B Surface Antigen Particles
Delpeyroux, F., Chenciner, N., Lim, A., Malpièce, Y., Blondel, B., Crainic, R., van der Werf, S., & Streeck, R. E. (1986) · Science · doi:10.1126/science.2425433 · Cited by 114
Insect cells as a production platform of complex virus-like particles
Fernandes, F., Teixeira, A. P., Carinhas, N., Carrondo, M. J. T., & Alves, P. M. (2013) · Expert Review of Vaccines · doi:10.1586/erv.12.153 · Cited by 102
Wahome, N., Pfeiffer, T., Ambiel, I., Yang, Y., Keppler, O. T., Bosch, V., & Burkhard, P. (2012) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2012.01423.x · Cited by 101
Nanoparticles as synthetic vaccines
Smith, J. D., Morton, L. D., & Ulery, B. D. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2015.03.014 · Cited by 101
Nardin, E. H., Oliveira, G. A., Calvo‐Calle, J. M., Wetzel, K., Maier, C., Birkett, A. J., Sarpotdar, P. P., Corado, M. L., Thornton, G. B., & Schmidt, A. (2004) · Infection and Immunity · doi:10.1128/iai.72.11.6519-6527.2004 · Cited by 99
Urakawa, T., Ferguson, M., Minor, P. D., Cooper, J., Sullivan, M., Almond, J. W., & Bishop, D. H. L. (1989) · Journal of General Virology · doi:10.1099/0022-1317-70-6-1453 · Cited by 97 · cited 1×
“In addition to the research and clinical development of the HPV nanoparticle vaccines, numerous other viruses (for example, rotavirus [50], poliovirus [51], herpesvirus [52], and parvovirus [53]) have been used to generate non-infectious VLPs as vaccine candidates, although currently mostly without successful clinical…”
Schwartzman, L. M., Cathcart, A. L., Pujanauski, L. M., Qi, L., Kash, J. C., & Taubenberger, J. K. (2015) · mBio · doi:10.1128/mbio.01044-15 · Cited by 97
Formation of protein micelles from amphiphilic membrane proteins.
Simons, K., Helenius, A., Leonard, K., Sarvas, M., & Gething, M.-J. H. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.11.5306 · Cited by 96
Cho, K. J., Shin, H. J., Lee, J.-H., Kim, K.-J., Park, S. S., Lee, Y., Lee, C., Park, S. S., & Kim, K. H. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.04.078 · Cited by 90
Leroux-Roels, G. G., Maes, C., Clément, F., van Engelenburg, F. A. C., van den Dobbelsteen, M., Adler, M., Amacker, M., Lopalco, L., Bomsel, M., Chalifour, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055438 · Cited by 87
Practical approaches to designing novel protein assemblies
King, N. P., & Lai, Y. (2013) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2013.06.002 · Cited by 86
Maturation of the Human Papillomavirus 16 Capsid
Giovanni Cardone, A., Moyer, A. L., Cheng, N., Thompson, C. D., Dvoretzky, I., Lowy, D. R., Schiller, J. T., Steven, A. C., Buck, C. B., & Trus, B. L. (2014) · mBio · doi:10.1128/mbio.01104-14 · Cited by 85
Influenza virus-like particle vaccines
Haynes, J. R. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.8 · Cited by 83
Burns, N. R., Saibil, H. R., White, N., Pardon, J. F., Timmins, P. A., Richardson, S. M., Richards, B. M., Adams, S. E., Kingsman, S. M., & Kingsman, A. J. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05156.x · Cited by 82
Viral vaccines and their manufacturing cell substrates: New trends and designs in modern vaccinology
Rodrigues, A. F., Soares, H. R., Guerreiro, M. R., Alves, P. M., & Coroadinha, A. S. (2015) · Biotechnology Journal · doi:10.1002/biot.201400387 · Cited by 77
He, L., Cheng, Y., Kong, L., Azadnia, P., Giang, E., Kim, J. J., Wood, M. R., Wilson, I. A., Law, M., & Zhu, J. (2015) · Scientific Reports · doi:10.1038/srep12501 · Cited by 77
Three‐dimensional structure of a mouse‐adapted type 2/type 1 poliovirus chimera.
Yeates, T. O., Jacobson, D., Martin, A., Wychowski, C., Girard, M. P., Filman, D. J., & Hogle, J. M. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07772.x · Cited by 75
Vaccination against nicotine: an emerging therapy for tobacco dependence
Maurer, P., & Bachmann, M. F. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.11.1775 · Cited by 75
Norovirus virus-like particle vaccines for the prevention of acute gastroenteritis
Richardson, C., Bargatze, R. F., Goodwin, R. R., & Mendelman, P. M. (2013) · Expert Review of Vaccines · doi:10.1586/erv.12.145 · Cited by 72
Structural description of the active sites of mouse L-chain ferritin at 1.2 Å resolution
Granier, T., d’Estaintot, B. L., Gallois, B., Chevalier, J.-M., PRECIGOUX, G., Santambrogio, P., & Arosio, P. (2003) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-002-0389-4 · Cited by 70
Protein Crystallography in Vaccine Research and Development
Malito, E., Carfí, A., & Bottomley, M. J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160613106 · Cited by 69
Self-citationPreclinical efficacy and safety of an anti-IL-1β vaccine for the treatment of type 2 diabetes
Spohn, G., Schori, C., Keller, I., Sladko, K., Sina, C., Guler, R., Schwarz, K., Johansen, P., Jennings, G. T., & Bachmann, M. F. (2014) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2014.48 · Cited by 63
Infectious enveloped RNA virus antigenic chimeras.
London, S., Schmaljohn, A. L., Dalrymple, J. M., & Rice, C. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.207 · Cited by 62
Treatment of drug-resistantShigellainfections
Klontz, K. C., & Singh, N. K. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.983902 · Cited by 61
Transplanting Supersites of HIV-1 Vulnerability
Zhou, T., Zhu, J., Yang, Y., Gorman, J., Ofek, G., Srivatsan, S. R., Druz, A., Lees, C. R., Lu, G., Soto, C. S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099881 · Cited by 61
Liu, Y. V., Massare, M. J., Pearce, M. B., Sun, X., Belser, J. A., Maines, T. R., Creager, H. M., Glenn, G. M., Pushko, P., Smith, G., et al. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.03.009 · Cited by 60
Mosquirix (RTS,S): A Novel Vaccine for the Prevention of Plasmodium falciparum Malaria
Wilby, K. J., Lau, T. T. Y., Gilchrist, S. E., & Ensom, M. H. H. (2012) · Annals of Pharmacotherapy · doi:10.1345/aph.1aq634 · Cited by 53
Sabara, M. I. J., Parker, M. L., Aha, P. M., Cosco, C., Gibbons, E., Parsons, S., & Babiuk, L. A. (1991) · Journal of Virology · doi:10.1128/jvi.65.12.6994-6997.1991 · Cited by 50
Feshchenko, E. A., Rhodes, D. G., Felberbaum, R., McPherson, C. E., Rininger, J. A., Post, P. L., & Cox, M. M. J. (2012) · BMC Biotechnology · doi:10.1186/1472-6750-12-77 · Cited by 49
Azevedo, M. S. P., Vlasova, A. N., & Saif, L. J. (2013) · Expert Review of Vaccines · doi:10.1586/erv.13.3 · Cited by 47
Chimeric Parvovirus B19 Capsids for the Presentation of Foreign Epitopes
Brown, C. S., Welling‐Wester, S., Feijlbrief, M., van Lent, J. W. M., & Spaan, W. J. M. (1994) · Virology · doi:10.1006/viro.1994.1059 · Cited by 41
Virus-like particle based vaccines for Alzheimer disease
Chackerian, B. (2010) · Human Vaccines · doi:10.4161/hv.6.11.12655 · Cited by 38
Prospects for Defined Epitope Vaccines for Respiratory Syncytial Virus
Anderson, R., Huang, Y. Y., & Langley, J. M. (2010) · Future Microbiology · doi:10.2217/fmb.10.22 · Cited by 36
Parvovirus-Like Particles as Vaccine Vectors
Casal, J. I., Rueda, P., & Hurtado, A. M. (1999) · Methods · doi:10.1006/meth.1999.0843 · Cited by 27
Yeates, T. O. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.127 · Cited by 24
Developments in virus-like particle-based vaccines for HIV
Buonaguro, L., Tagliamonte, M., Visciano, M. L., Tornesello, M. L., & Buonaguro, F. M. (2013) · Expert Review of Vaccines · doi:10.1586/erv.12.152 · Cited by 16
Zhang, L., Lu, J., Chen, Y., Shi, F., Yu, H., Huang, C., Cui, L., Shi, Z., Jiao, Y., & Hu, Y. (2015) · Viruses · doi:10.3390/v7082821 · Cited by 15
Cited by
Therapeutic Nanoparticles and Their Targeted Delivery Applications
Yetisgin, A. A., Cetinel, S., Zuvin, M., Kosar, A., & Kutlu, O. (2020) · Molecules · doi:10.3390/molecules25092193 · Cited by 1,080
Walls, A. C., Fiala, B., Schäfer, A., Wrenn, S., Pham, M. N., Murphy, M., Tse, L. V., Shehata, L., O’Connor, M. A., Chen, C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.043 · Cited by 532
“In contrast, self-assembling or particulate protein immunogens are a clinically validated vaccine modality with a proven track record of safety and efficacy in humans (López-Sagaseta et al., 2015).”
Marcandalli, J., Fiala, B., Ols, S., Perotti, M., de van der Schueren, W., Snijder, J., Hodge, E., Benhaim, M., Ravichandran, R., Carter, L., et al. (2019) · Cell · doi:10.1016/j.cell.2019.01.046 · Cited by 448
Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design
Rappuoli, R., Bottomley, M. J., D’Oro, U., Finco, O., & De Gregorio, E. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151960 · Cited by 435
Self-citationMosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice
Cohen, A. A., Gnanapragasam, P. N. P., Lee, Y. E., Hoffman, P. R., Ou, S., Kakutani, L. M., Keeffe, J. R., Wu, H.-J., Howarth, M., West, A. P., et al. (2021) · Science · doi:10.1126/science.abf6840 · Cited by 410
Metadata
- Authors
- López-Sagaseta, J., Malito, E., Rappuoli, R., & Bottomley, M. J.
- Venue
- Computational and Structural Biotechnology Journal
- Published
- 2016
- Volume
- 14
- Pages
- 58-68
- ISSN
- 2001-0370 (ISSN-L)
- OpenAlex
- W2172319351
- Cited by
- 353
- References
- 117
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.